These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis. Locher C; Koechlin H; Zion SR; Werner C; Pine DS; Kirsch I; Kessler RC; Kossowsky J JAMA Psychiatry; 2017 Oct; 74(10):1011-1020. PubMed ID: 28854296 [TBL] [Abstract][Full Text] [Related]
10. Clinical interventions for adults with comorbid alcohol use and depressive disorders: A systematic review and network meta-analysis. Grant S; Azhar G; Han E; Booth M; Motala A; Larkin J; Hempel S PLoS Med; 2021 Oct; 18(10):e1003822. PubMed ID: 34624018 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological interventions for somatoform disorders in adults. Kleinstäuber M; Witthöft M; Steffanowski A; van Marwijk H; Hiller W; Lambert MJ Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010628. PubMed ID: 25379990 [TBL] [Abstract][Full Text] [Related]
12. Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. Hausenblas HA; Saha D; Dubyak PJ; Anton SD J Integr Med; 2013 Nov; 11(6):377-83. PubMed ID: 24299602 [TBL] [Abstract][Full Text] [Related]
13. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis. Gosmann NP; Costa MA; Jaeger MB; Motta LS; Frozi J; Spanemberg L; Manfro GG; Cuijpers P; Pine DS; Salum GA PLoS Med; 2021 Jun; 18(6):e1003664. PubMed ID: 34111122 [TBL] [Abstract][Full Text] [Related]
14. The effects of saffron (Crocus sativus L.) on mental health parameters and C-reactive protein: A meta-analysis of randomized clinical trials. Ghaderi A; Asbaghi O; Reiner Ž; Kolahdooz F; Amirani E; Mirzaei H; Banafshe HR; Maleki Dana P; Asemi Z Complement Ther Med; 2020 Jan; 48():102250. PubMed ID: 31987241 [TBL] [Abstract][Full Text] [Related]
15. Selective serotonin reuptake inhibitors for premenstrual syndrome. Marjoribanks J; Brown J; O'Brien PM; Wyatt K Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001396. PubMed ID: 23744611 [TBL] [Abstract][Full Text] [Related]
16. Antidepressants plus benzodiazepines for adults with major depression. Ogawa Y; Takeshima N; Hayasaka Y; Tajika A; Watanabe N; Streiner D; Furukawa TA Cochrane Database Syst Rev; 2019 Jun; 6(6):CD001026. PubMed ID: 31158298 [TBL] [Abstract][Full Text] [Related]
17. Antidepressants for the treatment of depression in people with cancer. Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011006. PubMed ID: 29683474 [TBL] [Abstract][Full Text] [Related]
18. Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis. Jakobsen JC; Katakam KK; Schou A; Hellmuth SG; Stallknecht SE; Leth-Møller K; Iversen M; Banke MB; Petersen IJ; Klingenberg SL; Krogh J; Ebert SE; Timm A; Lindschou J; Gluud C BMC Psychiatry; 2017 Feb; 17(1):58. PubMed ID: 28178949 [TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy for anxiety and comorbid alcohol use disorders. Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826 [TBL] [Abstract][Full Text] [Related]
20. Vortioxetine for depression in adults. Koesters M; Ostuzzi G; Guaiana G; Breilmann J; Barbui C Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011520. PubMed ID: 28677828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]